Ultramicrosize Griseofulvin
NDC 42794-013, Ultramicrosize Griseofulvin, tablet, from Sigmapharm Laboratories, LLC.
- Product NDC
- 42794-013
- Status
- Listed
- Labeler
- Sigmapharm Laboratories, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202545
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42794-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN125 mg/1
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42794-013-08 | 42794001308 | 30 TABLET in 1 BOTTLE (42794-013-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/37b4d132-84f1-4394-b468-7e74eeec61ebNADAC price for package 42794001308
GET /v1/drugs/nadac/42794001308
Use it
Look up 42794-013 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42794-013 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42794-013. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.